nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—BCHE—malignant glioma	0.652	1	CbGaD
Mefloquine—HBA2—endothelium—malignant glioma	0.01	0.0989	CbGeAlD
Mefloquine—HBA2—blood vessel—malignant glioma	0.00926	0.0912	CbGeAlD
Mefloquine—HBA2—embryo—malignant glioma	0.00552	0.0544	CbGeAlD
Mefloquine—HBA1—brainstem—malignant glioma	0.00551	0.0543	CbGeAlD
Mefloquine—HBA1—telencephalon—malignant glioma	0.00489	0.0482	CbGeAlD
Mefloquine—HBA2—retina—malignant glioma	0.00488	0.0481	CbGeAlD
Mefloquine—CYP3A4—Temozolomide—malignant glioma	0.00384	1	CbGbCtD
Mefloquine—HBA1—spinal cord—malignant glioma	0.00343	0.0338	CbGeAlD
Mefloquine—HBA2—spinal cord—malignant glioma	0.00315	0.031	CbGeAlD
Mefloquine—HBA1—central nervous system—malignant glioma	0.00278	0.0274	CbGeAlD
Mefloquine—HBA1—cerebellum—malignant glioma	0.00272	0.0268	CbGeAlD
Mefloquine—HBA2—central nervous system—malignant glioma	0.00255	0.0251	CbGeAlD
Mefloquine—HBA2—cerebellum—malignant glioma	0.00249	0.0246	CbGeAlD
Mefloquine—Encephalopathy—Carmustine—malignant glioma	0.00246	0.0257	CcSEcCtD
Mefloquine—ADORA2A—telencephalon—malignant glioma	0.00234	0.023	CbGeAlD
Mefloquine—Paranoia—Carmustine—malignant glioma	0.00232	0.0242	CcSEcCtD
Mefloquine—HBA1—brain—malignant glioma	0.00221	0.0217	CbGeAlD
Mefloquine—Influenza-like symptoms—Temozolomide—malignant glioma	0.00214	0.0223	CcSEcCtD
Mefloquine—HBA2—brain—malignant glioma	0.00203	0.02	CbGeAlD
Mefloquine—ADORA1—telencephalon—malignant glioma	0.00202	0.0199	CbGeAlD
Mefloquine—ACHE—telencephalon—malignant glioma	0.00201	0.0198	CbGeAlD
Mefloquine—Memory impairment—Temozolomide—malignant glioma	0.00194	0.0203	CcSEcCtD
Mefloquine—Drug interaction—Carmustine—malignant glioma	0.0017	0.0178	CcSEcCtD
Mefloquine—Leukocytosis—Carmustine—malignant glioma	0.00168	0.0175	CcSEcCtD
Mefloquine—ADORA2A—spinal cord—malignant glioma	0.00164	0.0161	CbGeAlD
Mefloquine—Coordination abnormal—Carmustine—malignant glioma	0.00161	0.0168	CcSEcCtD
Mefloquine—Hearing impaired—Temozolomide—malignant glioma	0.0016	0.0167	CcSEcCtD
Mefloquine—ADORA1—medulla oblongata—malignant glioma	0.00159	0.0156	CbGeAlD
Mefloquine—ACHE—medulla oblongata—malignant glioma	0.00158	0.0155	CbGeAlD
Mefloquine—Coordination abnormal—Temozolomide—malignant glioma	0.00155	0.0162	CcSEcCtD
Mefloquine—Neuropathy—Carmustine—malignant glioma	0.00148	0.0155	CcSEcCtD
Mefloquine—Influenza like illness—Temozolomide—malignant glioma	0.00148	0.0155	CcSEcCtD
Mefloquine—ADORA1—midbrain—malignant glioma	0.00145	0.0143	CbGeAlD
Mefloquine—Coma—Carmustine—malignant glioma	0.00144	0.0151	CcSEcCtD
Mefloquine—ACHE—midbrain—malignant glioma	0.00144	0.0142	CbGeAlD
Mefloquine—Neuropathy—Temozolomide—malignant glioma	0.00143	0.015	CcSEcCtD
Mefloquine—Aplastic anaemia—Temozolomide—malignant glioma	0.00143	0.015	CcSEcCtD
Mefloquine—ADORA1—spinal cord—malignant glioma	0.00141	0.0139	CbGeAlD
Mefloquine—ACHE—spinal cord—malignant glioma	0.00141	0.0138	CbGeAlD
Mefloquine—ADORA2A—central nervous system—malignant glioma	0.00133	0.0131	CbGeAlD
Mefloquine—ADORA2A—cerebellum—malignant glioma	0.0013	0.0128	CbGeAlD
Mefloquine—Deafness—Temozolomide—malignant glioma	0.00124	0.0129	CcSEcCtD
Mefloquine—Hepatic failure—Temozolomide—malignant glioma	0.00123	0.0129	CcSEcCtD
Mefloquine—ADORA1—central nervous system—malignant glioma	0.00115	0.0113	CbGeAlD
Mefloquine—ADORA1—cerebellum—malignant glioma	0.00112	0.011	CbGeAlD
Mefloquine—ACHE—cerebellum—malignant glioma	0.00111	0.011	CbGeAlD
Mefloquine—BCHE—brainstem—malignant glioma	0.00111	0.0109	CbGeAlD
Mefloquine—Affect lability—Temozolomide—malignant glioma	0.00109	0.0114	CcSEcCtD
Mefloquine—Ataxia—Carmustine—malignant glioma	0.00108	0.0113	CcSEcCtD
Mefloquine—ADORA2A—brain—malignant glioma	0.00105	0.0104	CbGeAlD
Mefloquine—Mood swings—Temozolomide—malignant glioma	0.00105	0.011	CcSEcCtD
Mefloquine—Ataxia—Temozolomide—malignant glioma	0.00104	0.0109	CcSEcCtD
Mefloquine—Muscular weakness—Carmustine—malignant glioma	0.00101	0.0106	CcSEcCtD
Mefloquine—BCHE—telencephalon—malignant glioma	0.000986	0.00971	CbGeAlD
Mefloquine—Muscular weakness—Temozolomide—malignant glioma	0.000977	0.0102	CcSEcCtD
Mefloquine—ABCB1—blood vessel—malignant glioma	0.000968	0.00954	CbGeAlD
Mefloquine—ADORA1—brain—malignant glioma	0.000911	0.00897	CbGeAlD
Mefloquine—ACHE—brain—malignant glioma	0.000905	0.00892	CbGeAlD
Mefloquine—Pneumonia—Carmustine—malignant glioma	0.000888	0.00927	CcSEcCtD
Mefloquine—Renal failure—Carmustine—malignant glioma	0.000868	0.00906	CcSEcCtD
Mefloquine—Neuropathy peripheral—Carmustine—malignant glioma	0.000866	0.00904	CcSEcCtD
Mefloquine—Pneumonia—Temozolomide—malignant glioma	0.000858	0.00896	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000846	0.00883	CcSEcCtD
Mefloquine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000836	0.00873	CcSEcCtD
Mefloquine—Hepatobiliary disease—Temozolomide—malignant glioma	0.000807	0.00843	CcSEcCtD
Mefloquine—Hallucination—Carmustine—malignant glioma	0.000789	0.00824	CcSEcCtD
Mefloquine—Connective tissue disorder—Carmustine—malignant glioma	0.000779	0.00813	CcSEcCtD
Mefloquine—CYP19A1—central nervous system—malignant glioma	0.000778	0.00766	CbGeAlD
Mefloquine—BCHE—medulla oblongata—malignant glioma	0.000774	0.00763	CbGeAlD
Mefloquine—Visual impairment—Carmustine—malignant glioma	0.000764	0.00798	CcSEcCtD
Mefloquine—Hallucination—Temozolomide—malignant glioma	0.000762	0.00796	CcSEcCtD
Mefloquine—Connective tissue disorder—Temozolomide—malignant glioma	0.000753	0.00786	CcSEcCtD
Mefloquine—Eye disorder—Carmustine—malignant glioma	0.000741	0.00774	CcSEcCtD
Mefloquine—Visual impairment—Temozolomide—malignant glioma	0.000738	0.00771	CcSEcCtD
Mefloquine—CYP2D6—brainstem—malignant glioma	0.000736	0.00725	CbGeAlD
Mefloquine—Flushing—Carmustine—malignant glioma	0.000736	0.00768	CcSEcCtD
Mefloquine—Erythema multiforme—Temozolomide—malignant glioma	0.000724	0.00756	CcSEcCtD
Mefloquine—Eye disorder—Temozolomide—malignant glioma	0.000716	0.00747	CcSEcCtD
Mefloquine—Tinnitus—Temozolomide—malignant glioma	0.000714	0.00746	CcSEcCtD
Mefloquine—Cardiac disorder—Temozolomide—malignant glioma	0.000711	0.00742	CcSEcCtD
Mefloquine—Flushing—Temozolomide—malignant glioma	0.000711	0.00742	CcSEcCtD
Mefloquine—BCHE—midbrain—malignant glioma	0.000708	0.00697	CbGeAlD
Mefloquine—Alopecia—Carmustine—malignant glioma	0.0007	0.00731	CcSEcCtD
Mefloquine—Angiopathy—Temozolomide—malignant glioma	0.000695	0.00726	CcSEcCtD
Mefloquine—Mental disorder—Carmustine—malignant glioma	0.000694	0.00725	CcSEcCtD
Mefloquine—BCHE—spinal cord—malignant glioma	0.000691	0.0068	CbGeAlD
Mefloquine—Mediastinal disorder—Temozolomide—malignant glioma	0.00069	0.00721	CcSEcCtD
Mefloquine—Erythema—Carmustine—malignant glioma	0.00069	0.00721	CcSEcCtD
Mefloquine—Malnutrition—Carmustine—malignant glioma	0.00069	0.00721	CcSEcCtD
Mefloquine—Chills—Temozolomide—malignant glioma	0.000687	0.00718	CcSEcCtD
Mefloquine—Alopecia—Temozolomide—malignant glioma	0.000677	0.00707	CcSEcCtD
Mefloquine—Mental disorder—Temozolomide—malignant glioma	0.000671	0.00701	CcSEcCtD
Mefloquine—Malnutrition—Temozolomide—malignant glioma	0.000667	0.00696	CcSEcCtD
Mefloquine—Erythema—Temozolomide—malignant glioma	0.000667	0.00696	CcSEcCtD
Mefloquine—CYP2D6—telencephalon—malignant glioma	0.000653	0.00643	CbGeAlD
Mefloquine—Vision blurred—Carmustine—malignant glioma	0.00065	0.00679	CcSEcCtD
Mefloquine—Tremor—Carmustine—malignant glioma	0.000646	0.00675	CcSEcCtD
Mefloquine—Agitation—Carmustine—malignant glioma	0.000634	0.00662	CcSEcCtD
Mefloquine—Vision blurred—Temozolomide—malignant glioma	0.000628	0.00656	CcSEcCtD
Mefloquine—Tremor—Temozolomide—malignant glioma	0.000625	0.00652	CcSEcCtD
Mefloquine—Ill-defined disorder—Temozolomide—malignant glioma	0.000619	0.00646	CcSEcCtD
Mefloquine—Leukopenia—Carmustine—malignant glioma	0.000618	0.00645	CcSEcCtD
Mefloquine—CYP19A1—brain—malignant glioma	0.000618	0.00608	CbGeAlD
Mefloquine—Agitation—Temozolomide—malignant glioma	0.000613	0.0064	CcSEcCtD
Mefloquine—Malaise—Temozolomide—malignant glioma	0.000601	0.00628	CcSEcCtD
Mefloquine—Vertigo—Temozolomide—malignant glioma	0.000599	0.00626	CcSEcCtD
Mefloquine—Convulsion—Carmustine—malignant glioma	0.000598	0.00624	CcSEcCtD
Mefloquine—Leukopenia—Temozolomide—malignant glioma	0.000597	0.00623	CcSEcCtD
Mefloquine—Hypertension—Carmustine—malignant glioma	0.000596	0.00622	CcSEcCtD
Mefloquine—Palpitations—Temozolomide—malignant glioma	0.000589	0.00615	CcSEcCtD
Mefloquine—Chest pain—Carmustine—malignant glioma	0.000587	0.00613	CcSEcCtD
Mefloquine—Myalgia—Carmustine—malignant glioma	0.000587	0.00613	CcSEcCtD
Mefloquine—Anxiety—Carmustine—malignant glioma	0.000585	0.00611	CcSEcCtD
Mefloquine—Convulsion—Temozolomide—malignant glioma	0.000578	0.00603	CcSEcCtD
Mefloquine—ABCB1—embryo—malignant glioma	0.000578	0.00569	CbGeAlD
Mefloquine—Hypertension—Temozolomide—malignant glioma	0.000576	0.00601	CcSEcCtD
Mefloquine—Confusional state—Carmustine—malignant glioma	0.000568	0.00593	CcSEcCtD
Mefloquine—Arthralgia—Temozolomide—malignant glioma	0.000568	0.00593	CcSEcCtD
Mefloquine—Myalgia—Temozolomide—malignant glioma	0.000568	0.00593	CcSEcCtD
Mefloquine—Anxiety—Temozolomide—malignant glioma	0.000566	0.00591	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000564	0.00589	CcSEcCtD
Mefloquine—Oedema—Carmustine—malignant glioma	0.000563	0.00588	CcSEcCtD
Mefloquine—Discomfort—Temozolomide—malignant glioma	0.000561	0.00586	CcSEcCtD
Mefloquine—BCHE—central nervous system—malignant glioma	0.00056	0.00552	CbGeAlD
Mefloquine—Thrombocytopenia—Carmustine—malignant glioma	0.000551	0.00576	CcSEcCtD
Mefloquine—Tachycardia—Carmustine—malignant glioma	0.00055	0.00574	CcSEcCtD
Mefloquine—Confusional state—Temozolomide—malignant glioma	0.000549	0.00573	CcSEcCtD
Mefloquine—BCHE—cerebellum—malignant glioma	0.000548	0.0054	CbGeAlD
Mefloquine—Oedema—Temozolomide—malignant glioma	0.000544	0.00568	CcSEcCtD
Mefloquine—Anaphylactic shock—Temozolomide—malignant glioma	0.000544	0.00568	CcSEcCtD
Mefloquine—Nervous system disorder—Temozolomide—malignant glioma	0.000534	0.00557	CcSEcCtD
Mefloquine—Thrombocytopenia—Temozolomide—malignant glioma	0.000533	0.00556	CcSEcCtD
Mefloquine—Skin disorder—Temozolomide—malignant glioma	0.000529	0.00552	CcSEcCtD
Mefloquine—Hypotension—Carmustine—malignant glioma	0.000526	0.00549	CcSEcCtD
Mefloquine—Hyperhidrosis—Temozolomide—malignant glioma	0.000526	0.00549	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000513	0.00536	CcSEcCtD
Mefloquine—ABCB1—retina—malignant glioma	0.000511	0.00503	CbGeAlD
Mefloquine—Insomnia—Carmustine—malignant glioma	0.000509	0.00532	CcSEcCtD
Mefloquine—Paraesthesia—Carmustine—malignant glioma	0.000506	0.00528	CcSEcCtD
Mefloquine—Dyspnoea—Carmustine—malignant glioma	0.000502	0.00524	CcSEcCtD
Mefloquine—Somnolence—Carmustine—malignant glioma	0.000501	0.00523	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000496	0.00518	CcSEcCtD
Mefloquine—Insomnia—Temozolomide—malignant glioma	0.000492	0.00514	CcSEcCtD
Mefloquine—Decreased appetite—Carmustine—malignant glioma	0.00049	0.00511	CcSEcCtD
Mefloquine—Paraesthesia—Temozolomide—malignant glioma	0.000489	0.0051	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000486	0.00508	CcSEcCtD
Mefloquine—Dyspnoea—Temozolomide—malignant glioma	0.000485	0.00507	CcSEcCtD
Mefloquine—Somnolence—Temozolomide—malignant glioma	0.000484	0.00505	CcSEcCtD
Mefloquine—Dyspepsia—Temozolomide—malignant glioma	0.000479	0.005	CcSEcCtD
Mefloquine—Decreased appetite—Temozolomide—malignant glioma	0.000473	0.00494	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00047	0.00491	CcSEcCtD
Mefloquine—ABCB1—telencephalon—malignant glioma	0.00047	0.00463	CbGeAlD
Mefloquine—Fatigue—Temozolomide—malignant glioma	0.000469	0.0049	CcSEcCtD
Mefloquine—Feeling abnormal—Carmustine—malignant glioma	0.000464	0.00485	CcSEcCtD
Mefloquine—Gastrointestinal pain—Carmustine—malignant glioma	0.000461	0.00481	CcSEcCtD
Mefloquine—Feeling abnormal—Temozolomide—malignant glioma	0.000448	0.00468	CcSEcCtD
Mefloquine—Body temperature increased—Carmustine—malignant glioma	0.000445	0.00465	CcSEcCtD
Mefloquine—Abdominal pain—Carmustine—malignant glioma	0.000445	0.00465	CcSEcCtD
Mefloquine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000445	0.00465	CcSEcCtD
Mefloquine—BCHE—brain—malignant glioma	0.000445	0.00438	CbGeAlD
Mefloquine—Urticaria—Temozolomide—malignant glioma	0.000432	0.00451	CcSEcCtD
Mefloquine—Body temperature increased—Temozolomide—malignant glioma	0.00043	0.00449	CcSEcCtD
Mefloquine—Abdominal pain—Temozolomide—malignant glioma	0.00043	0.00449	CcSEcCtD
Mefloquine—Hypersensitivity—Carmustine—malignant glioma	0.000415	0.00433	CcSEcCtD
Mefloquine—Asthenia—Carmustine—malignant glioma	0.000404	0.00422	CcSEcCtD
Mefloquine—Hypersensitivity—Temozolomide—malignant glioma	0.000401	0.00419	CcSEcCtD
Mefloquine—Asthenia—Temozolomide—malignant glioma	0.00039	0.00408	CcSEcCtD
Mefloquine—Diarrhoea—Carmustine—malignant glioma	0.000385	0.00402	CcSEcCtD
Mefloquine—Pruritus—Temozolomide—malignant glioma	0.000385	0.00402	CcSEcCtD
Mefloquine—CYP3A4—central nervous system—malignant glioma	0.000377	0.00372	CbGeAlD
Mefloquine—Dizziness—Carmustine—malignant glioma	0.000372	0.00389	CcSEcCtD
Mefloquine—Diarrhoea—Temozolomide—malignant glioma	0.000372	0.00389	CcSEcCtD
Mefloquine—CYP2D6—central nervous system—malignant glioma	0.000371	0.00366	CbGeAlD
Mefloquine—ABCB1—medulla oblongata—malignant glioma	0.000369	0.00364	CbGeAlD
Mefloquine—CYP2D6—cerebellum—malignant glioma	0.000363	0.00357	CbGeAlD
Mefloquine—Dizziness—Temozolomide—malignant glioma	0.00036	0.00376	CcSEcCtD
Mefloquine—Vomiting—Carmustine—malignant glioma	0.000358	0.00374	CcSEcCtD
Mefloquine—Rash—Carmustine—malignant glioma	0.000355	0.00371	CcSEcCtD
Mefloquine—Dermatitis—Carmustine—malignant glioma	0.000355	0.0037	CcSEcCtD
Mefloquine—Headache—Carmustine—malignant glioma	0.000353	0.00368	CcSEcCtD
Mefloquine—Vomiting—Temozolomide—malignant glioma	0.000346	0.00361	CcSEcCtD
Mefloquine—Rash—Temozolomide—malignant glioma	0.000343	0.00358	CcSEcCtD
Mefloquine—Dermatitis—Temozolomide—malignant glioma	0.000343	0.00358	CcSEcCtD
Mefloquine—Headache—Temozolomide—malignant glioma	0.000341	0.00356	CcSEcCtD
Mefloquine—ABCB1—midbrain—malignant glioma	0.000337	0.00332	CbGeAlD
Mefloquine—Nausea—Carmustine—malignant glioma	0.000335	0.00349	CcSEcCtD
Mefloquine—ABCB1—spinal cord—malignant glioma	0.000329	0.00324	CbGeAlD
Mefloquine—Nausea—Temozolomide—malignant glioma	0.000323	0.00338	CcSEcCtD
Mefloquine—CYP2D6—brain—malignant glioma	0.000295	0.0029	CbGeAlD
Mefloquine—ABCB1—central nervous system—malignant glioma	0.000267	0.00263	CbGeAlD
Mefloquine—ABCB1—cerebellum—malignant glioma	0.000261	0.00257	CbGeAlD
Mefloquine—ABCB1—brain—malignant glioma	0.000212	0.00209	CbGeAlD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CG—malignant glioma	3.01e-05	0.000205	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS1—malignant glioma	3e-05	0.000204	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.99e-05	0.000203	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PIK3CB—malignant glioma	2.98e-05	0.000203	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PDGFRA—malignant glioma	2.97e-05	0.000202	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PTPN11—malignant glioma	2.95e-05	0.000201	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ASMT—malignant glioma	2.94e-05	0.000201	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—BCAN—malignant glioma	2.94e-05	0.0002	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOTCH2—malignant glioma	2.93e-05	0.0002	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.92e-05	0.000199	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—MMP2—malignant glioma	2.92e-05	0.000199	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CD—malignant glioma	2.91e-05	0.000198	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.89e-05	0.000197	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SPP1—malignant glioma	2.88e-05	0.000196	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—BCHE—malignant glioma	2.87e-05	0.000196	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KNG1—malignant glioma	2.87e-05	0.000196	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.87e-05	0.000195	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCL8—malignant glioma	2.87e-05	0.000195	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—SLC5A5—malignant glioma	2.84e-05	0.000193	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	2.8e-05	0.000191	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—BCAN—malignant glioma	2.77e-05	0.000189	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SLC5A5—malignant glioma	2.75e-05	0.000188	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AKT2—malignant glioma	2.75e-05	0.000187	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL2—malignant glioma	2.74e-05	0.000187	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NTRK1—malignant glioma	2.74e-05	0.000186	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.73e-05	0.000186	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TERT—malignant glioma	2.73e-05	0.000186	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.68e-05	0.000183	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PDGFB—malignant glioma	2.66e-05	0.000182	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.66e-05	0.000181	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGFR1—malignant glioma	2.65e-05	0.000181	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CD—malignant glioma	2.64e-05	0.00018	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	2.63e-05	0.000179	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HIF1A—malignant glioma	2.61e-05	0.000178	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.6e-05	0.000177	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—MMP2—malignant glioma	2.6e-05	0.000177	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.58e-05	0.000176	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP3—malignant glioma	2.54e-05	0.000173	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CB—malignant glioma	2.54e-05	0.000173	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CAV1—malignant glioma	2.53e-05	0.000172	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.52e-05	0.000172	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CDKN2B—malignant glioma	2.52e-05	0.000172	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KDR—malignant glioma	2.5e-05	0.00017	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTP1—malignant glioma	2.49e-05	0.000169	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTK2—malignant glioma	2.45e-05	0.000167	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCL8—malignant glioma	2.44e-05	0.000166	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CXCL8—malignant glioma	2.42e-05	0.000165	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CAT—malignant glioma	2.42e-05	0.000165	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HES1—malignant glioma	2.41e-05	0.000164	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—F2—malignant glioma	2.4e-05	0.000164	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FN1—malignant glioma	2.4e-05	0.000164	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NCOR1—malignant glioma	2.39e-05	0.000163	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—BAD—malignant glioma	2.38e-05	0.000162	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.37e-05	0.000162	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—IDH2—malignant glioma	2.37e-05	0.000161	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—RAF1—malignant glioma	2.36e-05	0.000161	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOTCH1—malignant glioma	2.35e-05	0.00016	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL2—malignant glioma	2.33e-05	0.000159	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.32e-05	0.000158	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CD80—malignant glioma	2.3e-05	0.000157	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CB—malignant glioma	2.3e-05	0.000157	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—APC—malignant glioma	2.3e-05	0.000157	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CG—malignant glioma	2.3e-05	0.000157	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PDGFRA—malignant glioma	2.29e-05	0.000156	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTP1—malignant glioma	2.28e-05	0.000156	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—NCOR1—malignant glioma	2.28e-05	0.000156	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EGF—malignant glioma	2.27e-05	0.000155	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—COX8A—malignant glioma	2.26e-05	0.000154	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTPN11—malignant glioma	2.26e-05	0.000154	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.25e-05	0.000153	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—IDH2—malignant glioma	2.23e-05	0.000152	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2B6—malignant glioma	2.23e-05	0.000152	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SPP1—malignant glioma	2.22e-05	0.000151	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CAT—malignant glioma	2.22e-05	0.000151	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTP1—malignant glioma	2.22e-05	0.000151	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL8—malignant glioma	2.21e-05	0.000151	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.19e-05	0.000149	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CXCL8—malignant glioma	2.16e-05	0.000147	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—BRAF—malignant glioma	2.16e-05	0.000147	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CAT—malignant glioma	2.16e-05	0.000147	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.14e-05	0.000146	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL2—malignant glioma	2.12e-05	0.000144	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TERT—malignant glioma	2.11e-05	0.000144	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKT2—malignant glioma	2.1e-05	0.000143	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—NCOR1—malignant glioma	2.1e-05	0.000143	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP2B6—malignant glioma	2.1e-05	0.000143	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EGFR—malignant glioma	2.1e-05	0.000143	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PDGFB—malignant glioma	2.06e-05	0.00014	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGFR1—malignant glioma	2.05e-05	0.000139	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NCOR1—malignant glioma	2.04e-05	0.000139	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—IDH1—malignant glioma	2.04e-05	0.000139	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.04e-05	0.000139	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CD—malignant glioma	2.02e-05	0.000138	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.02e-05	0.000138	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HIF1A—malignant glioma	2.02e-05	0.000137	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—PIK3CA—malignant glioma	2e-05	0.000136	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—KRAS—malignant glioma	1.98e-05	0.000135	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SPHK1—malignant glioma	1.97e-05	0.000134	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CAV1—malignant glioma	1.95e-05	0.000133	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGF2—malignant glioma	1.94e-05	0.000132	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP2C18—malignant glioma	1.93e-05	0.000131	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KDR—malignant glioma	1.93e-05	0.000131	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ASMT—malignant glioma	1.93e-05	0.000131	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—IDH1—malignant glioma	1.92e-05	0.000131	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CAV1—malignant glioma	1.86e-05	0.000127	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.86e-05	0.000126	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—F2—malignant glioma	1.86e-05	0.000126	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FN1—malignant glioma	1.86e-05	0.000126	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.85e-05	0.000126	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—BAD—malignant glioma	1.83e-05	0.000125	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.82e-05	0.000124	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PIK3CA—malignant glioma	1.82e-05	0.000124	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOTCH1—malignant glioma	1.82e-05	0.000124	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MDM2—malignant glioma	1.81e-05	0.000123	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—BCAN—malignant glioma	1.81e-05	0.000123	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RAF1—malignant glioma	1.81e-05	0.000123	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.79e-05	0.000122	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ERBB2—malignant glioma	1.79e-05	0.000122	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.78e-05	0.000121	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CD80—malignant glioma	1.78e-05	0.000121	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CG—malignant glioma	1.78e-05	0.000121	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APC—malignant glioma	1.78e-05	0.000121	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CB—malignant glioma	1.76e-05	0.00012	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EGF—malignant glioma	1.76e-05	0.00012	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTPN11—malignant glioma	1.74e-05	0.000119	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CAV1—malignant glioma	1.71e-05	0.000117	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CG—malignant glioma	1.7e-05	0.000116	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL8—malignant glioma	1.69e-05	0.000115	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—BRAF—malignant glioma	1.67e-05	0.000114	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CAV1—malignant glioma	1.66e-05	0.000113	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PPARG—malignant glioma	1.64e-05	0.000112	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AKT1—malignant glioma	1.64e-05	0.000111	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.64e-05	0.000111	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT2—malignant glioma	1.63e-05	0.000111	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP3—malignant glioma	1.62e-05	0.00011	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL2—malignant glioma	1.62e-05	0.00011	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EGFR—malignant glioma	1.62e-05	0.00011	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.59e-05	0.000108	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CD—malignant glioma	1.56e-05	0.000106	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTT1—malignant glioma	1.56e-05	0.000106	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CG—malignant glioma	1.56e-05	0.000106	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CA—malignant glioma	1.55e-05	0.000105	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—malignant glioma	1.53e-05	0.000104	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—KRAS—malignant glioma	1.53e-05	0.000104	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTEN—malignant glioma	1.52e-05	0.000104	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.52e-05	0.000103	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CG—malignant glioma	1.51e-05	0.000103	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARG—malignant glioma	1.5e-05	0.000102	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGF2—malignant glioma	1.49e-05	0.000102	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CD—malignant glioma	1.49e-05	0.000102	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AKT1—malignant glioma	1.49e-05	0.000101	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.47e-05	0.0001	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS1—malignant glioma	1.46e-05	9.97e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARG—malignant glioma	1.46e-05	9.95e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—IDH2—malignant glioma	1.46e-05	9.94e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CA—malignant glioma	1.4e-05	9.57e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MDM2—malignant glioma	1.4e-05	9.53e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RAF1—malignant glioma	1.39e-05	9.49e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ERBB2—malignant glioma	1.38e-05	9.39e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS1—malignant glioma	1.38e-05	9.39e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—malignant glioma	1.38e-05	9.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.37e-05	9.34e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CD—malignant glioma	1.37e-05	9.33e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—STAT3—malignant glioma	1.36e-05	9.28e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CB—malignant glioma	1.36e-05	9.27e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—BCHE—malignant glioma	1.36e-05	9.26e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC5A5—malignant glioma	1.34e-05	9.15e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CD—malignant glioma	1.33e-05	9.06e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL8—malignant glioma	1.31e-05	8.91e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CB—malignant glioma	1.3e-05	8.85e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—malignant glioma	1.29e-05	8.77e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—BCHE—malignant glioma	1.28e-05	8.73e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.27e-05	8.62e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MYC—malignant glioma	1.27e-05	8.62e-05	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AKT1—malignant glioma	1.26e-05	8.61e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—IDH1—malignant glioma	1.25e-05	8.55e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP3—malignant glioma	1.25e-05	8.53e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL2—malignant glioma	1.25e-05	8.51e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EGFR—malignant glioma	1.24e-05	8.43e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.24e-05	8.43e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SPHK1—malignant glioma	1.21e-05	8.27e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CB—malignant glioma	1.19e-05	8.14e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.19e-05	8.1e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—malignant glioma	1.18e-05	8.06e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—malignant glioma	1.18e-05	8.06e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTEN—malignant glioma	1.18e-05	8.01e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KRAS—malignant glioma	1.17e-05	7.97e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CB—malignant glioma	1.16e-05	7.9e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—malignant glioma	1.15e-05	7.83e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AKT1—malignant glioma	1.15e-05	7.81e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTEN—malignant glioma	1.12e-05	7.65e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTP1—malignant glioma	1.08e-05	7.37e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CA—malignant glioma	1.07e-05	7.32e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—malignant glioma	1.06e-05	7.23e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CAT—malignant glioma	1.05e-05	7.17e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—STAT3—malignant glioma	1.05e-05	7.16e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—malignant glioma	1.04e-05	7.08e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTEN—malignant glioma	1.03e-05	7.03e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTP1—malignant glioma	1.02e-05	6.95e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTEN—malignant glioma	1e-05	6.83e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NCOR1—malignant glioma	9.95e-06	6.77e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CAT—malignant glioma	9.92e-06	6.76e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MYC—malignant glioma	9.77e-06	6.66e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTT1—malignant glioma	9.62e-06	6.55e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EGFR—malignant glioma	9.56e-06	6.51e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NCOR1—malignant glioma	9.37e-06	6.38e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KRAS—malignant glioma	9.03e-06	6.15e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS1—malignant glioma	9.01e-06	6.14e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKT1—malignant glioma	8.78e-06	5.98e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—BCHE—malignant glioma	8.38e-06	5.71e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CA—malignant glioma	8.3e-06	5.65e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC5A5—malignant glioma	8.28e-06	5.64e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CAV1—malignant glioma	8.11e-06	5.52e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—malignant glioma	8.03e-06	5.47e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CA—malignant glioma	7.92e-06	5.4e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CAV1—malignant glioma	7.64e-06	5.2e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CG—malignant glioma	7.38e-06	5.03e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CA—malignant glioma	7.28e-06	4.96e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARG—malignant glioma	7.13e-06	4.85e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CA—malignant glioma	7.07e-06	4.82e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CG—malignant glioma	6.96e-06	4.74e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT1—malignant glioma	6.78e-06	4.62e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARG—malignant glioma	6.72e-06	4.57e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTP1—malignant glioma	6.67e-06	4.54e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CD—malignant glioma	6.49e-06	4.42e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CAT—malignant glioma	6.49e-06	4.42e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AKT1—malignant glioma	6.47e-06	4.41e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NCOR1—malignant glioma	6.13e-06	4.17e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CD—malignant glioma	6.12e-06	4.17e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AKT1—malignant glioma	5.95e-06	4.05e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AKT1—malignant glioma	5.78e-06	3.93e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CB—malignant glioma	5.66e-06	3.85e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—malignant glioma	5.61e-06	3.82e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CB—malignant glioma	5.33e-06	3.63e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—malignant glioma	5.28e-06	3.6e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CAV1—malignant glioma	4.99e-06	3.4e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTEN—malignant glioma	4.89e-06	3.33e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTEN—malignant glioma	4.61e-06	3.14e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.55e-06	3.1e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARG—malignant glioma	4.39e-06	2.99e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CD—malignant glioma	4e-06	2.72e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.49e-06	2.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—malignant glioma	3.45e-06	2.35e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CA—malignant glioma	3.45e-06	2.35e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.25e-06	2.21e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTEN—malignant glioma	3.01e-06	2.05e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AKT1—malignant glioma	2.82e-06	1.92e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AKT1—malignant glioma	2.66e-06	1.81e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.13e-06	1.45e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKT1—malignant glioma	1.74e-06	1.18e-05	CbGpPWpGaD
